Cargando…
Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants
The first-generation COVID-19 vaccines have been effective in mitigating severe illness and hospitalization, but recurring waves of infections are associated with the emergence of SARS-CoV-2 variants that display progressive abilities to evade antibodies, leading to diminished vaccine effectiveness....
Autores principales: | Kingstad-Bakke, Brock, Lee, Woojong, Chandrasekar, Shaswath S., Gasper, David J., Salas-Quinchucua, Cristhian, Cleven, Thomas, Sullivan, Jeremy A., Talaat, Adel, Osorio, Jorge E., Suresh, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171754/ https://www.ncbi.nlm.nih.gov/pubmed/35561224 http://dx.doi.org/10.1073/pnas.2118312119 |
Ejemplares similares
-
A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens
por: Chandrasekar, Shaswath S., et al.
Publicado: (2023) -
Zika virus like particles elicit protective antibodies in mice
por: Salvo, Mauricio A., et al.
Publicado: (2018) -
Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization
por: Chandrasekar, Shaswath S., et al.
Publicado: (2021) -
The Immunogenicity and Safety of Mycobacterium tuberculosis-mosR-Based Double Deletion Strain in Mice
por: Hildebrand, Rachel E., et al.
Publicado: (2023) -
BACH2 in TRegs Limits the Number of Adipose Tissue Regulatory T Cells and Restrains Type 2 Immunity to Fungal Allergens
por: Contreras, Amanda, et al.
Publicado: (2022)